The AHSN Network’s real-world evaluation programme aims to help innovators work with adopting organisations to secure the rapid rollout of new products.
The AHSN Network aims to ensure that innovators perform high-quality, relevant real-world evaluations that:
- demonstrate the value of a new product in real-world settings (outside of a controlled research environment)
- help organisations to implement new technology as easily as possible by building on learnings from previous rollouts in other organisations.
Read the AHSN Network guide: Real-World Evaluation to facilitate adoption at scale.
Some AHSNs have an ‘in-house’ ability to deliver this work, but many work with providers in the academic and private sectors to offer this service.
If you have an innovation that you believe can improve outcomes for patients in the UK and would like advice on conducting real-world evaluations, contact your local AHSN.
“Health equity is the attainment of the highest level of health for ALL people. Achieving health equity requires valuing everyone equally with focused and ongoing societal efforts to address avoidable inequalities, historical and contemporary injustices, and social determinants of health — and to eliminate disparities in health and health care.” (health.gov) Within the NHS there [...]
Sickle cell disease (SCD) is a serious and lifelong health condition. People with SCD produce unusually shaped red blood cells that can cause problems because they do not live as long as healthy blood cells and can block blood vessels. This can result in suffers experiencing painful episodes, called sickle cell crises, as well as anaemia, [...]
At the Royal Society of Medicine’s Tackling Inequalities conference it was clear from the passion in the room that great progress has been made across the system to better support some of our most under-served communities. To maintain this momentum, we must not just embed tackling health and healthcare inequalities in all that we do, [...]
